Evogliptin
CAS: 1222102-29-5
Ref. 3D-XYB10229
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Product Information
Evogliptin is an oral anti-diabetic drug that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is a potent inhibitor of P-glycoprotein, which may affect its absorption, distribution, metabolism and excretion. Evogliptin has been shown to reduce the risk of congestive heart failure in patients with type 2 diabetes mellitus by reducing inflammation and oxidative stress. The pharmacokinetics of evogliptin have been studied in vitro using human macrophages and in vivo using healthy volunteers and patients with type 2 diabetes mellitus. Evogliptin also reduces hepatic steatosis and hepatic impairment as well as human macrophages.
Chemical properties
Technical inquiry about: 3D-XYB10229 Evogliptin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
